The UK-based firm plans to marry its core strengths with the probes and PCR platforms, and to build its sales force in the US.
LGC said it plans to use Douglas Scientific's PCR and qPCR platforms to provide customers with enhanced high-throughput genotyping and qPCR instruments.
The two companies will use KeyGene's technology for the genetic analysis of field and vegetable crops.
The investment firm says it will acquire LGC for an undisclosed amount.
LGC will offer TraitGenetics' SNP genotyping services using Illumina and Affymetrix array technologies to its global customers.
The three-year deal includes more than 100,000 pre-designed assays for public domain human SNPs.
Registered users of the IBP will have access to a range of genotyping services through LGS.
The acquisition will enable LGC to deliver product and laboratory service offerings for core qPCR and end-point PCR applications, as well as NGS.
LGC will distribute Holliston, Mass.-based AutoGen's FlexStar, Arrow, and QuickGene platforms in Europe, the Middle East, and Africa.
Bio-Rad this week announced the launch of PrimePCR Rat Genome Assays for qPCR.
In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.
A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.
Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.
Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.